Predictive biomarkers for ovarian cancer
US9846158B2 · kind B2 · utility
2Cited by
58References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2016 |
| Grant date | Dec 19, 2017 |
| Priority date | — |
| Expiry date | Feb 11, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods are provided for predicting the presence, subtype and stage of ovarian cancer, as well as for assessing the therapeutic efficacy of a cancer treatment and determining whether a subject potentially is developing cancer. Associated test kits, computer and analytical systems as well as software and diagnostic models are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.